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of entering physician orders directly into an electronic health record.
Although CPOE has been shown to improve medication safety and
reduce health care costs, these improvements have been demon-
strated largely in the inpatient setting; the cost-effectiveness in the
ambulatory setting remains uncertain. Objective: The objective
was to estimate the cost-effectiveness of CPOE in reducing medication
errors and adverse drug events (ADEs) in the ambulatory
setting. Methods: We created a decision-analytic model to estimate
the cost-effectiveness of CPOE in a midsized (400 providers) multi-
disciplinary medical group over a 5-year time horizon— 2010 to 2014—
the time frame during which health systems are implementing CPOE
to meet Meaningful Use criteria. We adopted the medical group’s
perspective and utilized their costs, changes in efﬁciency, and
actual number of medication errors and ADEs. One-way and proba-
bilistic sensitivity analyses were conducted. Scenario analyses
were explored. Results: In the base case, CPOE dominated paperee front matter Copyright & 2014, International S
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98195.prescribing, that is, CPOE cost $18 million less than paper prescribing,
and was associated with 1.5 million and 14,500 fewer medication
errors and ADEs, respectively, over 5 years. In the scenario that
reﬂected a practice group of ﬁve providers, CPOE cost $265,000
less than paper prescribing, was associated with 3875 and 39
fewer medication errors and ADEs, respectively, over 5 years, and
was dominant in 80% of the simulations. Conclusions: Our
model suggests that the adoption of CPOE in the ambulatory setting
provides excellent value for the investment, and is a cost-effective
strategy to improve medication safety over a wide range of
practice sizes.
Keywords: adverse drug events, ambulatory care, computerized
physician order entry system, cost-beneﬁt analysis (cost-effectiveness),
medication errors.
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In 2009, United States Congress passed the American Recovery
and Reinvestment Act, a seminal piece of legislation focused on
health care reform [1]. The act includes the $19 billion Health
Information Technology for Economic and Clinical Health provi-
sion, which has spurred electronic health record (EHR) adoption
[2]. Also promoting EHR adoption are ﬁnancial incentives from
the Centers for Medicare & Medicaid Services (CMS) to providers
who demonstrate Meaningful Use [3]. At the top of the list of
stage 1 Meaningful Use criteria is implementation of the compu-
terized provider order entry (CPOE) system.
Published systematic reviews suggest that CPOE is associated
with a 13% to 99% reduction in medication errors and a 30% to
84% reduction in adverse drug events (ADEs) [4,5]. In the ambu-
latory setting, our group found that CPOE, even with limited
clinical decision support alerts to guide ordering, is associated
with a 55% reduction in errors [6]. Although early problems with
drop-down boxes [7], resistance to adoption [8], workﬂowdisruption [9–11], increased workload [9–11], and even increased
numbers of errors [12] have been reported, CPOE has gained
traction over the past 5 years and is now an integral part of the
learning health care system [13,14]. Current research is address-
ing alert fatigue using methods of human factors engineering
[15,16]. Workﬂow has emerged as an area of focus [17]. Work
continues to iteratively improve CPOE systems with clinical
decision support alerts to further reduce medication errors and
improve prescriber adherence to guidelines [18–20].
One of the major barriers to the adoption of CPOE (and EHRs)
has long been the large up-front investment. Meaningful Use
incentives reduce this cost barrier, thereby promoting increased
uptake, with the ultimate goal of improving patient safety.
However, few studies have estimated the long-term costs of
CPOE relative to its safety beneﬁts. Studies conducted in the
ambulatory setting have demonstrated a positive return on
investment in an EHR [21,22], and similar ﬁndings have been
noted in inpatient settings when evaluating CPOE [23,24]. One
study estimated the cost-effectiveness of an electronicociety for Pharmacoeconomics and Outcomes Research (ISPOR).
omes Research and Policy Program, University of Washington, Box
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setting [25], but we found no such study in ambulatory care. Our
objective was to estimate the cost-effectiveness of CPOE versus
traditional paper-based prescribing in reducing medication errors
and ADEs in the ambulatory care setting of a midsized (400
providers) medical group.Methods
Setting
The Everett Clinic is the largest independent, physician-owned
medical group in Washington state. Based in the North Puget
Sound, The Everett Clinic is a multispecialty clinic system
comprising more than 400 prescribers, approximately equally
distributed between primary care and specialty physicians, with
a growing number of mid-level providers. These clinicians pro-
vide care for more than 300,000 patients within 60 clinics in 16
locations, and admit to primarily one community hospital in the
local market. The Everett Clinic contracts with approximately 18
health plans, each with its own formulary; clinicians order 2.7
million prescriptions annually. In 1995, The Everett Clinic devel-
oped a homegrown EHR. The system was Web-based, used point-
and-click functionality, and integrated electronic prescribing into
an existing EHR that included scheduling, chart notes, and
laboratory and imaging reports. Basic CPOE software was
designed in 2004 and rolled out from 2004 through 2006, and
generated new and reﬁll prescriptions. The drug database was
provided by Multum (Cerner, Denver, CO). Clinicians selected
medications from pull-down menus or “favorites” lists. Clinical
decision support alerts were limited to basic dosing guidance,
duplicate therapy checks, and pediatric dosing calculations.
Clinic staff could queue prescriptions; prescribers signed and
released them. Prescriptions could be electronically transmitted
to more than 200 local pharmacies. Prescribing at the point of
care demanded a fundamental shift in workﬂow and required a
computer to be installed in each examination room. Our groupFig. 1 – Decision analytic model. ADE, adverse drughas previously evaluated the effect of this CPOE implementation
on medication errors and ADEs [6], and on prescriber and staff
time [26].The Model
Adding the CPOE module to an existing homegrown EHR pro-
vided a unique opportunity to estimate the cost-effectiveness of
the CPOE system separate from the EHR. A decision-analytic
model was created using Microsoft Excel (Redmond, WA) to
conduct a cost-effectiveness analysis of The Everett Clinic’s CPOE
system. Although we considered modeling both the cost-beneﬁt
and the cost-utility of the CPOE system, in this case, we were
interested in estimating the cost per medication error or ADE
averted; hence, cost-effectiveness analysis was the method of
choice. The perspective of the medical group was chosen because
the medical group incurs implementation costs and realizes the
beneﬁt of improved prescription accuracy and safety. Patients
beneﬁt from improved medication safety.
The model compares prescriptions that were hand-written
before CPOE implementation (paper-based) with those prescribed
after CPOE implementation, and evaluates prescriptions written
annually, per provider. The use of either a paper-based or a CPOE
system could lead to a clinical (e.g., drug–drug interaction) or
administrative (e.g., illegibility) medication error, and each med-
ication error could lead to a potential ADE (no harm) or prevent-
able ADE (harm) (Fig. 1) [6]. The two outcome measures were the
number of medication errors avoided and the number of ADEs
avoided. We chose a 5-year time horizon (2010–2014) to model the
effect of CPOE in accordance with CMS Meaningful Use incentives
[3]. These incentives, in the amount of $44,000 over 5 years (2011–
2015), are awarded to each eligible participating provider who
meets certain prescribing criteria [3]. We designed our model to
reﬂect a medical group that anticipates meeting these criteria,
and therefore, express all year 1 modeling costs in 2010 US
dollars. Costs are discounted 3% annually for each of the
remaining 4 years of the time horizon.event; CPOE, computerized provider order entry.
Table 1 – Cost and medication error/ADE inputs: Base-case and scenario analyses.
Model parameters Paper system
(range)
CPOE system
(range)
Distribution
used in PSA
COSTS*
CPOE system costs (The Everett Clinic data)
CPOE hardware, software, and maintenance costs† (thousands) ($)
Year 1, 2010 NA 373 (355–392) Normal
Year 2, 2011 NA 675 (642–709) Normal
Year 3, 2012 NA 541 (514–568) Normal
Year 4, 2013 NA 92 (88–97) Normal
Year 5, 2014 NA 92 (88–97) Normal
Personnel costs‡ (CliniTech and The Everett Clinic employees) (thousands) ($)
Year 1, 2010 NA 555 (528–583) Normal
Year 2, 2011 NA 625 (493–656) Normal
Year 3, 2012 NA 639 (607–671) Normal
Year 4, 2013 NA 639 (607–671) Normal
Year 5, 2014 NA 639 (607–671) Normal
Indirect costs (%) NA 3% of CPOE system
and personnel costs
Beta
Administrative costs
Total The Everett Clinic prescriptions written per year
(millions) (The Everett Clinic data)
2.7 (2.65–2.84) 2.7 (2.65–2.84) Normal
Annual rate of increase in prescriptions written (%) 1 (0.1–2) 1 (0.1–2) Beta
Chart pulls (The Everett Clinic data)
Charts pulled per day per provider 10 (5–12) 5 (3–7)§ Normal
Days worked per provider per year 224 (202–246) 224 (202–246) Normal
Cost per chart pull ($) 5 (3–7) 5 (3–7) Normal
Prescription queuing [26]
RN time per Rx (s) 83.2 (70.6–96.1) 76.0 (64.4–87.5) Normal
MA time per Rx (s) 114.1 (96.8–131.4) 133.9 (113.8–154.1) Normal
Rx queued by an RN (% of all Rxs) 40 (32–48) 40 (32–48) Beta
Rx queued by an MA (% of all Rxs) 18 (14–21) 27 (22–32) Beta
Time spent prescribing, per prescriber [26]
New prescription (s) 47.16 (39.96–54.00) 74.88 (63.72–86.40) Normal
Reﬁll prescription(s) 46.08 (39.24–52.92) 60.12 (51.12–69.12) Normal
Prescribing costs
Number of providers (The Everett Clinic data) and compensation [29]
Primary care providers (PCPs) (n) 129 (116–142) 129 (116–142) Normal
Hourly salary ($), PCP 81 (72–89) 81 (72–89) Normal
Annual rate of increase in PCPs employed (%) 1 (0.5–1.5) 1 (0.5–1.5) Beta
Mid-level providers (MLPs) (n) 25 (23–28) 25 (23–28) Normal
Hourly salary ($), MLP 51 (46–56) 51 (46–56) Normal
Annual rate of increase in MLPs employed (%) 5 (3–7) 5 (3–7) Beta
Specialty providers (n) 226 (203–249) 226 (203–249) Normal
Hourly salary ($), specialty provider 106 (95–142) 106 (95–142) Normal
Annual rate of increase in specialty providers
employed (%)
1 (0.5–1.5) 1 (0.5–1.5) Beta
Hourly salary ($), RN 36 (32–40) 36 (32–40) Normal
Hourly salary ($), MA 17 (15–18) 17 (15–18) Normal
Hourly salary ($), OA 17 (16–20) 17 (16–20) Normal
FINANCIAL INCENTIVES
Incentive-eligible prescribers (The Everett Clinic data) (%) 0 72 Normal
HITECH Meaningful Use incentives, per prescriber [3] ($)
Year 1, 2010 NA 0 Normal
Year 2, 2011 NA 18,000 Normal
Year 3, 2012 NA 12,000 Normal
Year 4, 2013 NA 8,000 Normal
Year 5, 2014|| NA 4,000 Normal
Pay-for-performance incentives
Ofﬁce visits per year (thousands) (The Everett Clinic data) 650 (625–675) 650 (625–675) Normal
Annual rate of increase in visits (%) 1 (0.5–1.5) 1 (0.5–1.5) Beta
10-min visits (%) 5 (4–6) 5 (4–6) Beta
15-min visits (%) 35 (30–40) 35 (30–40) Beta
continued on next page
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Table 1 – continued
Model parameters Paper system
(range)
CPOE system
(range)
Distribution
used in PSA
25-min visits (%) 40 (35–45) 40 (35–45) Beta
40-min visits (%) 10 (8–12) 10 (8–12) Beta
CMS reimbursement, per patient per visit [30] ($)
10-min visit 40 (36–44) 40 (36–44) Normal
15-min visit 65 (58–71) 65 (58–71) Normal
25-min visit 98 (88–108) 98 (88–108) Normal
40-min visit 133 (120– 146) 133 (120–146) Normal
EVENTS [6]
Medication error and ADE probabilities (as proportion of total prescriptions)
Probability of medication error 0.182 0.067 Lognormal
Clinical medication error 0.073 0.043 Lognormal
Potential ADE 0.072 0.042 Lognormal
Preventable ADE 0.001 0.001 Lognormal
Administrative medication error 0.108 0.024 Lognormal
Potential ADE 0.108 0.024 Lognormal
Preventable ADE 0 0 Lognormal
SCENARIO 4: SMALL PRACTICE MODEL
Cost of CPOE implementation (year 1) [35] ($) NA 3,921 Normal
Cost of CPOE maintenance (years 2 through 5) [35] ($) NA 2,209 Normal
Number of patients per panel [37] 1,800 1,800 Normal
ADE, adverse drug event; CMS, Centers for Medicare & Medicaid Services; CPOE, computerized provider order entry; HITECH, Health
Information Technology for Economic and Clinical Health; MA, medical assistant; NA, not applicable; OA, ofﬁce assistant; PSA, probabilistic
sensitivity analysis; RN, registered nurse; Rx, prescriptions; The Everett Clinic data—The Everett Clinic, data from ﬁnancial accounting records.
* All costs are in 2010 US dollars.
† Hardware costs in year 1 reﬂect wireless installation; hardware costs in years 2 and 3 reﬂect switch to wired installation of computers in
most examination rooms; hardware costs in years 4 and 5 reﬂect installation in remainder of the examination rooms; the expected life of
hardware is 5 years. Software costs include the cost of the operating system, drug database, and virus protection; maintenance costs include
costs for maintaining secure Internet connections and costs for parts and labor for failed equipment.
‡ Personnel costs reﬂect software development, software maintenance and updating, testing and training, and ongoing help desk support.
Personnel costs are included for the following types of personnel, each working part-time on CPOE implementation: one project manager,
two programmers, one network security administrator, one database administrator, and one application support person. The help desk was
staffed by one technical person and two clinical pharmacists who specialized in CPOE implementation.
§ For ﬁrst year only.
|| Meaningful Use incentives truncated at year 4 to align with 5-y life of computer hardware.
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The point estimates and respective ranges for all cost and error/
ADE probability inputs are listed in Table 1. The base-case
analysis includes the system costs of implementing and main-
taining the CPOE system (hardware, software, maintenance,
personnel), administrative costs (chart pulls for prescription
reﬁlls, time spent by staff queuing prescriptions), prescribing
costs (time spent by prescribers conducting prescribing tasks),
and two types of prescribing incentives (pay-for-performance
[P4P] and Meaningful Use). Year over year increases in dollars
account for the growth in the number of patients cared for at The
Everett Clinic, which resulted in increases in numbers of pre-
scribers and staff hired, number of visits, and number of pre-
scriptions written.System Costs
System costs represent those actually incurred by The Everett
Clinic for CPOE installation during the ﬁrst 3 years (2004–2006)
and those incurred on an annual, recurring basis from years 1
through 5 (2004–2008). Hardware costs in year 1 reﬂect wireless
installation; hardware costs in years 2 through 5 reﬂect the
switch to wired installation of a computer in most examination
rooms. Maintenance costs include the costs of maintaining
secure Internet connections and costs of parts and labor forfailed equipment. The expected life of the hardware is 5 years.
Software costs include the cost of the operating system, drug
database, and virus protection. The software was developed and
the system was installed and maintained by professionals
employed by The Everett Clinic’s health information technology
subsidiary, CliniTech. Personnel costs were incurred in each year
and reﬂect software development, maintenance, and updating;
testing and training; and ongoing help desk support. Because the
CPOE system was implemented incrementally over 2 years, no
decrease in productivity was experienced. A 3% indirect overhead
rate is added to all system and personnel costs. These reﬂect
actual dollars spent, as recorded by The Everett Clinic’s ﬁnancial
accounting system, and are inﬂation-adjusted to 2010 using the
consumer price index for medical care [27].
Administrative and Prescribing Costs
Administrative costs consist of paper chart pulls, registered nurse
and medical assistant time spent queuing prescriptions, and
prescriber time spent prescribing. The number of chart pulls
included is limited to those estimated to be needed to evaluate
prescription reﬁlls only and include the time and cost of medical
records personnel to retrieve and re-ﬁle the chart [28]. In the ﬁrst
year of CPOE, chart pulls were estimated to be reduced by one-
half, then dropped to zero for subsequent years, as all paper
charts were eliminated at The Everett Clinic. Registered nurse
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prescriber time spent prescribing was based on the number of
prescriptions ﬁlled at The Everett Clinic per year, the number of
physicians and staff employed, and the time spent prescribing.
Estimates for time spent queuing and prescribing were taken
directly from a direct observation time-motion study previously
conducted by our group [26]. Prescribing time reﬂects time spent
prescribing before CPOE implementation and after system use
reached stability and reﬂects the same time frame as does
system costs. We applied mean compensation, by occupation,
supplied by the Bureau of Labor Statistics [29]. All administrative
and prescribing cost data are set in 2010.Incentives
When The Everett Clinic meets prespeciﬁed quality benchmark-
ing criteria, the P4P incentives are awarded annually by the
health plans with which it contracts. These take the form of a
premium paid per ambulatory care visit. For purposes of the cost-
effectiveness analysis model, the only incentive we applied was
that of adopting a CPOE system. We conservatively estimate that
CPOE adoption comprises a small portion of the P4P incentive
and estimate it at 3% above Medicare’s rate for primary care ofﬁce
visits [30]. Increased revenue from each patient visit was
assumed to start in year 1 (2010). For CMS criteria, we conserva-
tively applied 32% of the total amount of each annual Meaningful
Use incentive payment to the model, reasoning that CPOE criteria
comprise a signiﬁcant proportion but not all of the total EHR
stage 1 Meaningful Use criteria [3,31].Table 2 – Types of errors, administrative and clinical [6],
Types of errors Proportion of prescriptions
each error type before C
implementation (%)
Clinical
Contraindication for patients Z65 y 0.5
Drug allergy 0.2
Drug–disease interaction 0.5
Drug–drug interaction 0.5
Lack of appropriate laboratory
monitoring
2.0
Therapeutic duplication 0.3
Wrong directions 2.4
Wrong dosage form 0.1
Wrong dose 0.2
Wrong drug 0.3
Wrong route 0
Wrong strength 0.3
Total proportion of prescriptions with
clinical errors
7.3
Administrative
Illegible writing 2.0
Inappropriate abbreviations 4.8
Missing information 3.8
Wrong patient 0.1
Wrong physician 0.1
Total proportion of prescriptions with
administrative errors
10.8
Total proportion of prescriptions with
any type of error
18.2
CPOE, computerized provider order entry; PSA, probabilistic sensitivity aMedication Errors and ADEs
We use our previously published data evaluating the effect of a
CPOE system on medication errors and ADEs to populate the
event probabilities in our model [6]. These probabilities were
obtained from a sample size of more than 10,000 prescriptions
that were evaluated for medication errors and ADEs. In this
sample, approximately 14% of the patients were older than 65
years and 58% were female; more than 70% of the prescriptions
were ordered by primary care physicians (including pediatri-
cians), 14% by specialty providers, and less than 10% by urgent
care providers. Between 15% and 18% of the prescriptions were
written for antibiotics, 19% for controlled substances, 10% for
central nervous system agents, 6% for antidepressants, 7% for
hormones, and 40% for others [6]. We classify errors as 1 of 17
types (Table 2). We then categorize each of these as clinical or
administrative, to distinguish errors for which lack of clinical
information could have contributed to an error (e.g., drug–lab
monitoring) from those for which clinical information would not
play a role (e.g., illegibility), respectively. If a prescription were
found to have more than one medication error, the most severe
was chosen. Medication errors were linked to ADEs through chart
review, and severity was classiﬁed using the rating system of the
National Coordinating Council on Medication Error Reporting and
Prevention [32]. All clinical errors were associated with either
potential (levels B–D; no harm) or preventable ADEs (levels E–F;
harm); all administrative errors were associated with potential
ADEs. Data reﬂect the number of medication errors and ADEs that
occurred before CPOE implementation and after system use
reached stability and reﬂects the same time frame as do system
costs [6]. We have no reason to believe that the proportion ofand probabilities.
with
POE
Proportion of prescriptions with
each error type after CPOE
implementation (%)
Distribution
used in PSA
0.2 Lognormal
0 Lognormal
0.2 Lognormal
0.3 Lognormal
2.1 Lognormal
0.3 Lognormal
1.6 Lognormal
0.1 Lognormal
0.2 Lognormal
0.2 Lognormal
0 Lognormal
0.1 Lognormal
5.3
0 Lognormal
0.4 Lognormal
2.5 Lognormal
0 Lognormal
0 Lognormal
2.9
8.2
nalysis.
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time, so have set these estimates in 2010. As with costs, increases
in the number of errors and ADEs, year over year, reﬂect
increases in the number of patients cared for at The Everett
Clinic, and therefore increased number of prescriptions. All out-
comes are then discounted at 3% per annum from 2011
through 2014.
Sensitivity Analyses
We conducted one-way and probabilistic sensitivity analyses on
all model parameters. The results of the one-way sensitivity
analyses identify inputs with the greatest effect on results. We
conducted a probabilistic sensitivity analysis using Monte Carlo
simulation methods (10,000 simulation runs) to examine joint
uncertainty in model outcomes, applying a distribution suitable
to each parameter (Table 2), and calculate the net monetary
beneﬁt of each strategy [33]. These results are plotted as cost-
effectiveness acceptability curves to evaluate the cost-
effectiveness of the CPOE strategy over a plausible range of
willingness to pay for the CPOE system.
Scenario Analyses
We explore four scenario analyses. Because CPOE implementa-
tion at The Everett Clinic reﬂects an add-on module to a
preexisting, homegrown EHR, the incremental costs reﬂected in
our base case are likely lower than those incurred when a CPOE
system is initially implemented in conjunction with a vendor-
purchased EHR. In the latter situation, the entire system is new,
implementation costs higher, and training requirements more
intense. Acknowledging this reality, in scenario 1, we double the
costs in the base case to better reﬂect the effect of a more
expensive CPOE system. In scenario 2, we assume that The
Everett Clinic achieved no reduction in paper chart pulls through-
out the 5-year time horizon, to explore the effect of inefﬁciency
from running a paper and electronic system in parallel. In
scenario 3, we assume Meaningful Use incentives are not avail-
able and explore the effect of lack of this cost offset on
implementation costs.
Last, in scenario 4, we decrease the size of the medical group. In
the United States, approximately 55% of physician ofﬁces are solo
practices, 41% are groups between 2 and 10 providers, 3% are
groups between 11 and 19 providers, and the remaining 1% are
groups of 20 or more physicians [34]. As our base case reﬂects a
medical group that falls into this last category, scenario 4 models a
smaller medical group, of 5 providers (varied from 1 to 20 providers
in the sensitivity analyses). Because of our concern that imple-
mentation processes of CPOE systems in a small medical group
may be fundamentally different from those experienced by The
Everett Clinic, we used system implementation and maintenance
costs obtained from the literature and created a “small practice
model.” We chose costs for a stand-alone e-prescribing system,
often installed in small practices, which is similar in features and
functionality to The Everett Clinic’s CPOE system (basic, with little
clinical decision support that would be available if fully integrated
with a complete EHR, yet with the capability of transmitting
prescriptions electronically) [35]. These system costs include hard-
ware, software, personnel, and training, and were $3900 (2010 US
dollars) per provider during the implementation year and $2900
(2010 US dollars) per provider per year during each maintenance
year [36]. Evidence suggests that there is no decline in productivity
during the implementation of an e-prescribing system [35], which
was also similar to The Everett Clinic’s experience. We assume all
providers are primary care providers and estimate the size of their
practice panel using an equation provided by the American
Academy of Family Practice [37]. We retained the number ofprescriptions written per prescriber per year, and the proportions
of prescriptions with medication errors and ADEs used in The
Everett Clinic base-case and other scenario analyses, because we
found no reason to believe that these patterns would be dependent
on practice size. The cost of chart pulls, provider salaries, and
incentive payments also remain the same.Results
Base Case
In the base case, the CPOE strategy cost $18 million less than
paper-based prescribing and is associated with 1.5 million fewer
errors and 14,500 fewer ADEs. Accordingly, CPOE is the dominant
strategy. The probabilistic sensitivity analysis conﬁrms that CPOE
is the dominant strategy in 99.6% and 98.9% of the Monte Carlo
simulations for medication errors and ADEs, respectively
(Table 3). One-way sensitivity analyses reveal that the largest
drivers of uncertainty in the models are the salary and number of
specialty care providers, the number and cost of chart pulls, and
the number of prescriptions ordered per year (Fig. 2). The cost-
effectiveness acceptability curve illustrates the probability that
the CPOE system is cost-effective at various levels of willingness
to pay per ADE avoided. For the base case, the probability that the
CPOE system is cost-effective is more than 98% until willingness
to pay reaches approximately $16,000, when it drops slightly,
remaining steady at more than 97% for the remainder of the
levels (Fig. 3).
Scenario 1
Doubling the costs of the base case, CPOE cost $13 million less
than paper-based prescribing and is dominant in 97% of the
simulations (Table 3). The most inﬂuential cost drivers in this
scenario are the same as those in the base case (see Appendix 1
in Supplemental Materials found at http://dx.doi.org/10.1016/j.
jval.2014.01.009). The probability of the CPOE system being cost-
effective is stable at 99% for almost all levels of willingness to pay
(see Appendix 2 in Supplemental Materials found at http://dx.doi.
org/10.1016/j.jval.2014.01.009).
Scenario 2
When we model no reduction in chart pulls, CPOE remains the
dominant strategy for medication errors, with an incremental
cost-effectiveness ratio of $110 per ADE averted. For both med-
ication errors and ADEs averted, CPOE remains dominant in 50%
of the simulations (Table 3). Again, in the one-way sensitivity
analyses, the same parameters drive the largest changes in the
model (see Appendix 1 in Supplemental Materials found at http://
dx.doi.org/10.1016/j.jval.2014.01.009). The probability that the
CPOE system is cost-effective is just below 50% when willingness
to pay is less than $200, but rises rapidly to more than 99%
thereafter (see Appendix 2 in Supplemental Materials found at
http://dx.doi.org/10.1016/j.jval.2014.01.009).
Scenario 3
Eliminating Meaningful Use incentives did not have an appreci-
able effect over the base case, saving $14 million to reduce errors
by 1.5 million and ADEs by 14,500 over 5 years. CPOE is dominant
in 98% to 99% of the simulations (Table 3). The cost drivers in the
one-way sensitivity analysis remained the same, and the prob-
ability of the CPOE system being cost-effective is stable at 100% at
all levels of willingness to pay (see Appendices 1 and 2 in
Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.
2014.01.009).
Table 3 – Results—Base case and scenarios 1 through 4.
Result Paper system
(range*)
CPOE system
(range*)
Difference
(range*)
CPOE
dominated†
(less costly
and more
effective) (%)
CPOE more
costly and
more
effective (%)†
The Everett Clinic base case
Cost (millions) ($)‡ 43 (20–69) 25 (13–38) 18 (44 to 5)
Errors (millions) 2.3 (2.1–2.6) 0.9 (0.5–1.5) 1.5 (1.8 to 0.7) 99.6 0.4
ADEs (thousands) 21.8 (19.7–24.8) 7.3 (1.6–41) 14.5 (21.2 to 18.9) 98.9 0.4
The Everett Clinic scenario 1: Base case with CPOE costs doubled
Cost (millions) ($)‡ 43 (22–67) 29 (18–) 13 (38 to 13)
Errors (millions) 2.3 (2.1–2.6) 0.9 (0.5–1.5) 1.5 (1.8 to 0.7) 97.6 2.4
ADEs (thousands) 21.8 (19.7–24.8) 7.3 (1.6–41) 14.5 (21.2 to 18.9) 96.9 2.4
The Everett Clinic scenario 2: No reduction in chart pulls
Cost (millions) ($)‡ 42 (21–70) 44 (19–77) 1.6 (36 to 47)
Errors (millions) 2.3 (2.1–2.6) 0.8 (0.5–1.4) 1.5 (1.8 to 0.8) 50.5 49.5
ADEs (thousands) 21.8 (19.9–24.5) 7.3 (1.4–41) 14.5 (21.4 to 15.6)
ICER ¼ $110/ADE
avoided
50.1 49.1
The Everett Clinic scenario 3: Exclusion of Meaningful Use incentives
Cost (millions) ($)‡ 42 (22–67) 29 (18–41) 14 (41 to 10)
Errors (millions) 2.3 (2.1–2.6) 0.9 (0.5–1.5) 1.5 (1.8 to 0.7) 98.3 1.7
ADEs (thousands) 21.8 (19.7–24.8) 7.3 (1.6–41) 14.5 (21.2 to 18.9) 97.6 1.7
Scenario 4: Small practice model (ﬁve providers)
Cost (thousands) ($)‡ 478 (65–2,819) 213 (48–1,029) 265 (2,510 to 826)
Errors (thousands) 6,099 (5,552–7,003) 2,224 (1,468–3,644) 3,875 (4,946 to 2,008) 80.4 19.6
ADEs (hundreds) 58 (53–67) 19 (4–137) 39 (55 to 38) 80.0 19.5
ADE, adverse drug event; CPOE, computerized provider order entry; ICER, incremental cost- effectiveness ratio.
* Range for 10,000 Monte-Carlo simulations.
† Percent of Monte-Carlo simulations.
‡ In 2010 US dollars.
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Dominance of the CPOE system is maintained when modeling
medical groups with small numbers of providers. With a practice
comprising ﬁve providers, CPOE saves $265,000 and results inFig. 2 – One-way sensitivity analyses—The Everett Clinic base ca
(2010 US dollars). Small practice model costs are in thousands (20
RBRVS25, Resource-based Relative Value Scale cost for a 25-minut3,875 fewer medication errors and 39 fewer ADEs, respectively,
over 5 years. CPOE is dominant in 80% of the simulations
(Table 3). In this scenario, the one-way sensitivity analysis high-
lights that the number of primary care providers is anse and small practice model. Base-case costs are in millions
10 US dollars). CPOE, computerized provider order entry;
e clinic visit; P4P, pay for performance; TEC, The Everett Clinic.
Fig. 3 – Scatter plots and cost-effectiveness acceptability curves—The Everett Clinic base case and small practice model. ADE,
adverse drug event; CPOE, computerized provider order entry; TEC, The Everett Clinic.
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 3 4 0 – 3 4 9 347exceptionally large driver of costs; far less so is their salary, the
number of prescriptions per year, and, again, the number of chart
pulls (Fig. 2). This is logical because in this model, both the
implementation costs and the number of patients and prescrip-
tions are based on the number of prescribers. In the other
scenarios, the number of patients and prescriptions were drawn
from The Everett Clinic’s actual experience. The probability that
the CPOE is cost-effective is 80% when the willingness to pay per
ADE avoided is $0 and rises slowly to more than 95% at
approximately $10,000 (Fig. 3).Table 4 – Comparison of parameter inputs in The
Everett Clinic model and the small practice model.
Parameter The Everett
Clinic model
The small
practice
model
(reference)
Cost of CPOE
implementation
(year 1) ($)
2443 3921 [36]
Cost of CPOE maintenance
(years 2 through 5) ($)
Year 2: 3301* 2209 [33]
Year 3: 2890*
Year 4: 1705
Year 5: 1644
Number of patients
per panel
1900 1800 [37]
Number of prescriptions
per patient per year†
10 10 [The Everett
Clinic Model]
* The Everett Clinic costs are larger in years 2 and 3 due to the
timing of installation of computers in examination rooms.
† Mean number of prescriptions per capita per year in Washington
state ¼ 11; mean number of prescriptions per capita per year in
the United States ¼ 12.Constructing a model that reﬂects small practice sizes pro-
vided us an opportunity to compare parameters used in The
Everett Clinic model with those used in the small practice model.
Speciﬁcally, when we compared the cost of the CPOE system per
prescriber and the size of the practice panel at The Everett Clinic
(calculated from aggregate numbers from The Everett Clinic’s
ﬁnancial management system) with these same parameters used
in the small practice model (obtained from the literature on a per-
prescriber basis), they were quite similar (Table 4). These ﬁndings
support the validity and generalizability of The Everett Clinic
model. Similarly, the prescription volume per patient per year for
The Everett Clinic model was calculated from aggregate Everett
Clinic data (10 prescriptions per year), and then used in the small
practice model. Comparing this value with the same from the
literature, we found that the number of prescriptions ﬁlled per
capita per year in Washington state is 11 and in the United States
is 12 [38]. This further validates and supports the generalizability
of The Everett Clinic model (Table 4).Discussion
In the base case, the adoption of CPOE and cessation of paper
prescribing resulted in lower costs and improved medication
safety from the medical group perspective. Neither doubling the
costs nor elimination of Meaningful Use incentives signiﬁcantly
altered the results. In scenario 2, wherein we modeled no chart
pull reduction over 5 years, the proportion of simulations
wherein CPOE was the dominant strategy was cut almost in half.
The results of our modeling exercise suggest that the dominance
of the CPOE strategy is closely tied to a rapid reduction in chart
pulls and, by extension, to the elimination of paper charts. The
commitment to elimination of paper charts, on the part of a
medical group, is an ambitious undertaking and indicates a full
commitment to the electronic storage of data [28].
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assumptions that were in favor of paper prescribing, and sup-
ported by our model design. That is, ﬁrst, we considered chart
pulls solely for reﬁll requests, excluding those pulled for new
prescriptions, for addressing medication errors, and for other
clinical reasons. Including these costs would have increased the
costs of the paper strategy. Second, prescribing time using CPOE
was reﬂective of time spent prescribing in the examination room,
which takes longer [26]. Third, at the time of data collection, the
CPOE system implemented by The Everett Clinic included only
basic clinical decision support functionality. Had more sophisti-
cated functionality been available, additional medication errors
may have been identiﬁed [6]. For these reasons, our model may
have underestimated the beneﬁt of CPOE. The application of
CPOE may result in more dramatic cost savings and improved
safety for other medical groups if the baseline number of paper
chart pulls is higher using the paper strategy, computers are not
installed in examination rooms, or more sophisticated clinical
decision support alerts are part of the CPOE system [23–25].
However, groups adopting CPOE but unable to fully transition
away from pulling charts may not realize a cost saving as great as
that seen at The Everett Clinic. That eliminating the Meaningful
Use incentives did not change the results should not deter health
systems from implementing CPOE systems because the ﬁnding
that CPOE implementation was less expensive and resulted in
improved medication safety, when compared with paper-based
prescribing, was almost universal in our models.
Modeling the cost-effectiveness of using an e-prescribing
system in small medical groups (small practice model) was a
useful exercise, and it further conﬁrmed that implementing such a
system, even in a small practice (o20 providers), is of high value—
saving costs while improving medication safety. This should
encourage small provider groups that have not yet done so to
consider adoption. That approximately 95% of the medical groups
in the United States are of this small size suggests that national
policies to spur adoption reﬂect good value for money. That this
exercise also enabled us to validate The Everett Clinic model
suggests that the ﬁndings of this model may be generalizable to
other midsized medical groups as well. A recently published report
suggests that the largest medical group in the United States is the
Kaiser Permanente Medical Group (Santa Clara, CA), with 7842
physicians; the 2nd largest, the Cleveland Clinic, with 1472
physicians; and the 50th largest, Health Partners (St. Paul, MN),
with 398 physicians [34]. With 355 physicians (and 25 mid-level
providers), The Everett Clinic does not rank in the top 50, but it is
still the largest independent medical group in the state of Wash-
ington. As such, we feel that the results of our base case may be
generalizable to medical groups of similar size but not necessarily
larger, because it is likely that the largest medical groups are
structurally and operationally different from The Everett Clinic.
Approximately 4.5 million ADE-related ambulatory visits
occur annually in the United States, with most of these being in
the outpatient ofﬁces of primary care physicians [39]. The cost of
treating an ADE in the ambulatory setting is approximately $771
(inﬂated to 2010 US dollars) [40]. A recent estimate of the cost of
treating a preventable medication-related hospital admission
was €5641 (US $7786) [41], with average production loss costs
per admission of €1712 (US $2363) for a person younger than 65
years. This sums to €6009 (US $8294) per admission. With more
than 95% probability that a CPOE system will be cost-effective at a
willingness-to-pay threshold of approximately $10,000 to avoid
an ADE, the evidence is robust that the implementation of a CPOE
system provides good value for money and improves medication
safety.
Our study is limited by the fact that the basic CPOE system
implemented by The Everett Clinic was homegrown, and costs
were undoubtedly lower than those of medical groupsimplementing a complete, vendor-purchased EHR today. Estimat-
ing the cost-effectiveness of an EHR, however, was not our
question of interest, so we did not take into account the effect
of changes in costs of dictation, transcription, or accounting,
billing or charge capture; space for medical records; or other EHR
elements. These limitations are balanced by two key strengths.
First, we based our medication error and ADE probabilities, and
time estimates, on data collected at The Everett Clinic during the
time frame of CPOE implementation. Second, our model inputs
reﬂect national averages for implementation costs, physician
panel size, and prescriptions ordered per capita per year.
We believe that this is the ﬁrst study to estimate the cost-
effectiveness of CPOE in the ambulatory setting, separate from an
EHR. Our ﬁndings suggest that provider groups adopting CPOE
and eliminating paper prescribing have the potential to rapidly
improve medication safety while reducing costs to the health
care system.
For groups unable to implement a full EHR all at once, CPOE—
or a basic e-prescribing system—can be an important ﬁrst step,
with demonstrated patient safety and cost-saving beneﬁts. Our
ﬁndings support initiatives of the Institute of Medicine [42] and
the CMS [3] to encourage the adoption of CPOE and electronic
prescribing because, at our site, CPOE alone resulted in increased
medication safety and resulted in cost savings to the system.Conclusions
Adoption of CPOE in the ambulatory setting of midsize group
practices provides excellent value for the investment and is a
cost-effective strategy to improve medication safety. These same
results may be applied to practices with fewer providers that
implement a basic e-prescribing system.Acknowledgments
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